首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Tetrahydronaphthyl azole oxime ethers: the conformationally rigid analogues of oxiconazole as antibacterials.
【24h】

Tetrahydronaphthyl azole oxime ethers: the conformationally rigid analogues of oxiconazole as antibacterials.

机译:四氢萘基唑肟醚:作为抗菌剂的奥昔康唑的构象刚性类似物。

获取原文
获取原文并翻译 | 示例
           

摘要

A series of novel (Z)- and (E)-2-imidazolo-/triazolo-methyl tetrahydronaphthyl oxime ethers (7-28) were synthesized as conformationally constrained analogues of oxiconazole and evaluated for antifungal and antibacterial activities. Many of these derivatives exhibited potent antibacterial activity and surprisingly none of them was active against fungal strains. The SAR studies showed that imidazole oxime ethers were more active than the corresponding triazole oxime ethers. Imidazole derivatives 8, 11, 12, 15, 18, 19, 21 and 23 exhibited high inhibitory activity with 1.56-0.39 microg/mL MIC values against Klebsiella pneumoniae, Escherichia coli and Staphylococcus aureus. These compounds represent new structure scaffolds that can be further optimized to give new antibacterial agents with structures significantly different from those of existing classes of antibiotics.
机译:合成了一系列新颖的(Z)-和(E)-2-咪唑并/三唑并甲基四氢萘肟肟醚(7-28),将其作为肟康唑的构象约束类似物,并评估了其抗真菌和抗菌活性。这些衍生物中的许多表现出有效的抗菌活性,并且令人惊讶地,它们都不具有对抗真菌菌株的活性。 SAR研究表明,咪唑肟醚比相应的三唑肟醚更具活性。咪唑衍生物8、11、12、15、18、19、21和23对肺炎克雷伯菌,大肠埃希菌和金黄色葡萄球菌均显示出高抑制活性,MIC值为1.56-0.39 microg / mL。这些化合物代表了新的结构支架,可以进一步优化以提供新的抗菌剂,其结构与现有抗生素类别明显不同。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号